Every Form 4 that MaxLinear, Inc. (MXL) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow MXL and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MXL filings page.
MAXLINEAR, INC (MXL) reported that officer Connie H. Kwong exercised restricted stock units and had shares withheld in connection with that event. On August 31, 2026, 1,110 RSUs were converted into 1,110 shares of Common Stock, and 1,110 shares were delivered or withheld for payment of exercise price or tax liability at $59.91 per share. The RSUs stem from an award of 8,506 RSUs that vests 25% annually each August 20, fully vesting on August 20, 2026.
MAXLINEAR, INC (MXL) reported that Chairman, President and CEO Kishore Seendripu, through entities associated with him, reported indirect sales of 591,454 shares of Common Stock on August 14 and 17, 2026. These sales were executed in multiple tranches at weighted average prices generally ranging from about $82.83 to $88.72 per share, as detailed in price-range footnotes. All reported sale entries are marked as indirect ownership, primarily through various family and heritage trusts; several of these trusts carry footnote language in which Seendripu disclaims Section 16 beneficial ownership except to the extent of any pecuniary interest. Separately, he is shown as holding 924,083 shares directly of MaxLinear common stock as of August 14, 2026.
MAXLINEAR, INC director Thomas E. Pardun reported an insider transaction involving common stock. On May 26, 2026, the Thomas E. Pardun Irrevocable Trust, an entity associated with him, completed an open-market sale of 11,000 common shares at $105 per share.
Following this sale, the trust held 55,252 common shares indirectly, while Pardun also held 12,141 common shares directly. The filing reflects a net reduction of 11,000 shares in his reported holdings, combining both direct and indirect positions disclosed.
MaxLinear, Inc. Corporate Controller & PAO Connie H. Kwong reported routine equity compensation activity involving restricted stock units (RSUs). On May 25, 2026, 3,713 RSUs converted into an equal number of common shares, and the company withheld 3,713 shares to cover tax obligations. After these transactions, she directly held 18,356 shares of common stock. Footnotes clarify this was related to previously deferred RSU vesting and was not an open-market trade.
MaxLinear director Albert J. Moyer exercised previously deferred equity awards into common stock. On May 20, 2026, he converted 40,336 restricted stock units (RSUs) into an equal number of MaxLinear common shares, reflecting the settlement of RSUs that each represent a contingent right to one share.
The footnotes explain that Moyer had deferred settlement of these RSUs until he left the board or a qualifying change in control. His retirement from the board on May 20, 2026 triggered this settlement, and he now holds 113,129 common shares directly. No open-market purchases or sales are reported in this filing.
Sennesael Kris reported acquisition or exercise transactions in this Form 4 filing.
MAXLINEAR, INC director Kris Sennesael received a grant of 1,963 restricted stock units. Each RSU represents a contingent right to receive one share of MaxLinear common stock.
The RSUs will fully vest on the earlier of May 1, 2027 or the date immediately before the next annual stockholder meeting, as long as Sennesael continues serving as a director.
ARTUSI DANIEL A reported acquisition or exercise transactions in this Form 4 filing.
MaxLinear director Daniel A. Artusi received a new equity award in the form of restricted stock units. On May 20, 2026, he was granted 1,963 RSUs, each representing a contingent right to receive one share of MaxLinear common stock. Following this grant, his reported derivative holdings from this filing consist of these 1,963 RSUs.
The award will vest 100% on the earlier of May 1, 2027 or the date immediately preceding MaxLinear’s next annual meeting of stockholders, provided he continues to serve as a Director under the company’s 2010 Equity Incentive Plan.
Tewksbury Ted L III reported acquisition or exercise transactions in this Form 4 filing.
MAXLINEAR, INC reported that director Ted L. Tewksbury III received a grant of 1,963 Restricted Stock Units. Each RSU represents a contingent right to receive one share of MaxLinear common stock. The RSUs will vest 100% on the earlier of May 1, 2027 or the date immediately preceding the next annual meeting of stockholders, as long as he continues serving as a director.
PARDUN THOMAS E reported acquisition or exercise transactions in this Form 4 filing.
MAXLINEAR, INC director Thomas E. Pardun received a grant of 1,963 Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of MaxLinear common stock as equity compensation rather than an open-market purchase.
All 1,963 RSUs will vest in a single installment, subject to Pardun continuing to serve as a director, on the earlier of May 1, 2027 or the date immediately preceding MaxLinear’s next annual meeting of stockholders. Following this award, Pardun holds 1,963 RSUs directly.
Dougherty Greg reported acquisition or exercise transactions in this Form 4 filing.
MAXLINEAR, INC director Greg Dougherty received an equity award in the form of 1,963 restricted stock units (RSUs). Each RSU represents a right to receive one share of MaxLinear common stock. The entire award is scheduled to vest on May 1, 2027, or immediately before the next annual stockholder meeting, provided he continues serving as a director.
BEAVER CAROLYN reported acquisition or exercise transactions in this Form 4 filing.
MAXLINEAR, INC director Carolyn Beaver received a grant of 1,963 restricted stock units (RSUs). These RSUs give her the right to receive an equal number of MaxLinear common shares at vesting. Following the grant, she holds 1,963 RSUs directly.
The award vests in full if she continues serving as a director until the earlier of May 1, 2027, or the date immediately before the next annual stockholder meeting. No shares were bought or sold in the market; this is a stock-based compensation grant.
MAXLINEAR, INC Chairman, President and CEO Kishore Seendripu reported routine equity compensation activity involving restricted stock units (RSUs). On May 20, 2026, RSUs covering 33,682 shares of Common Stock converted into 33,682 shares at a stated price of $0.00 per share.
To satisfy tax obligations on this vesting, 33,682 shares of Common Stock were withheld at $96.77 per share, a non-market tax-withholding disposition rather than an open-market sale. After these transactions, Seendripu directly held 924,083 shares of Common Stock and 132,400 RSUs. Various family, annuity, relatives and heritage trusts, plus a donor advised fund, also hold additional indirect positions in MaxLinear shares, where he or related parties serve as trustee, co-trustee or advisor, with certain trusts subject to Section 16 beneficial ownership disclaimers.
MAXLINEAR, INC corporate officer sells shares in open-market trades. Corporate Controller & Principal Accounting Officer Connie H. Kwong reported selling a total of 35,000 shares of MAXLINEAR common stock in two open-market transactions at prices around $96.92 and $97.15 per share. After these sales, she holds 13,947 shares directly. A footnote explains that 28,461 of the shares were sold at a weighted average price within a narrow range, indicating multiple executions within that band.
MaxLinear director Ted L. Tewksbury III reported a combination of equity vesting and stock sales in MaxLinear, Inc. common stock. On May 1, 2026, 15,741 restricted stock units (RSUs) fully vested, converting into the same number of common shares.
Between May 1 and May 5, 2026, he executed open-market sales totaling 10,660 shares at prices around $77–$80 per share. These transactions were carried out under a pre-arranged Rule 10b5-1 trading plan. After the reported trades, he directly holds 80,076 common shares of MaxLinear.
MaxLinear, Inc. director Kris Sennesael acquired 2,052 shares of Common Stock through RSU vesting. On May 1, 2026, 100% of a Restricted Stock Unit award vested, and each RSU converted into one share of MaxLinear Common Stock. Following this transaction, Sennesael directly holds 2,052 Common shares. The filing shows a routine compensation-related RSU vesting and derivative exercise with no open-market buying or selling.
MaxLinear director Carolyn Beaver reported an RSU vesting and partial share sale. On May 1, 2026, 15,741 restricted stock units converted into the same number of MaxLinear common shares, following 100% vesting of the award on that date.
On May 4, 2026, she completed an open‑market sale of 6,000 common shares at a weighted average price of $76.9578 per share, with individual trades between $76.95 and $77.03. After these transactions, Beaver directly holds 33,316 MaxLinear shares.
MaxLinear, Inc. director Albert J. Moyer reported a routine compensation-related share exercise followed by a sale. On May 1, 2026, 15,741 restricted stock units vested, and he acquired the same number of common shares through a derivative exercise.
On May 4, 2026, he conducted an open-market sale of 15,741 common shares at $78.00 per share. After these transactions, Moyer directly held 72,793 shares of MaxLinear common stock.
MAXLINEAR, INC director Daniel A. Artusi reported both an equity award vesting and a share sale. On May 1, 2026, 15,741 restricted stock units vested and were converted into the same number of common shares at a $0.00 exercise price. On May 4, 2026, he completed an open-market sale of 10,500 common shares at a weighted average price of $78.6408 per share, across a price range of $78.60 to $78.76. Following these transactions, he holds 17,382 common shares directly.
MAXLINEAR, INC Corporate Controller & PAO Connie H. Kwong reported an open-market sale of 4,118 shares of Common Stock at $58.00 per share on April 29, 2026. Following this sale, she directly holds 48,947 shares of MaxLinear common stock.
MaxLinear, Inc. executive Connie H. Kwong, the Corporate Controller & PAO, reported an open-market sale of 15,050 shares of Common Stock. The weighted average sale price was $51.2922 per share, and she now directly holds 53,065 shares following this transaction.
MAXLINEAR, INC officer Steven G. Litchfield reported selling a total of 44,929 shares of MaxLinear common stock in open-market transactions. The sales occurred on March 4, 5, and 6, 2026, at weighted average prices of $17.4959, $16.8061, and $15.6836 per share, respectively.
After these sales, he directly owned 343,435 shares of MaxLinear common stock. This holding includes 326 shares acquired under the company’s 2010 Employee Stock Purchase Plan on November 15, 2025, as noted in the filing footnotes.
MaxLinear, Inc. Corporate Controller & PAO Connie H. Kwong reported multiple equity award transactions on March 2, 2026. Several batches of restricted stock units were converted into common stock, while portions of the resulting shares were withheld at a price of $17.99 per share to cover tax obligations. After these exercises and tax-withholding dispositions, Kwong directly owned 68,115 shares of MaxLinear common stock.
MaxLinear, Inc. Chairman, President and CEO Kishore Seendripu reported a set of equity compensation transactions dated March 2, 2026. He acquired Common Stock through the vesting and settlement of restricted stock units (RSUs), including 13,543 and 76,883 RSUs, and 90,426 shares from derivative exercises at a stated price of $0.00 per share.
To cover tax withholding obligations on these awards, 31,048, 27,421 and 90,426 shares of Common Stock were disposed of at $17.99 per share, characterized as tax-withholding dispositions rather than open-market sales. Footnotes describe multiple family and estate-planning trusts that hold additional shares, some of which the reporting person disclaims as beneficially owned except for any pecuniary interest.
MaxLinear, Inc. Corporate Controller & PAO Connie H. Kwong reported equity awards in the form of common stock and restricted stock units. On February 20, 2026, she acquired 9,231 shares of common stock under the company’s Executive Incentive Bonus Plan for the 2025 performance period, and 1,702 additional shares tied to 2025 financial performance conditions, with both issuances made under the Amended and Restated 2010 Equity Incentive Plan. On February 18, 2026, she received 14,219 restricted stock units, each representing one share of common stock, vesting in three equal annual installments starting May 20, 2027 and becoming fully vested on May 20, 2029, contingent on continued service.
MAXLINEAR, INC officer Steven G. Litchfield reported a series of equity award and vesting transactions in company stock and restricted stock units. On February 20, 2026, he acquired 3,074 and 26,241 shares through restricted stock unit conversions, and 29,315 shares of Common Stock through a derivative exercise.
He also received Common Stock grants of 25,978 shares tied to the 2025 performance period under the executive bonus plan and 19,441 shares upon achievement of 2025 performance conditions, all under the 2010 Equity Incentive Plan. To cover tax obligations, 42,532 shares of Common Stock were disposed of at $18.47 per share, recorded as a tax-withholding transaction rather than an open-market sale.
In addition, on February 18, 2026, Litchfield was granted 58,234 restricted stock units, each representing one share of Common Stock. These RSUs vest over multiple years, with specified tranches scheduled to vest between February 20, 2027 and May 20, 2029, contingent on his continued service.
SEENDRIPU KISHORE reported acquisition or exercise transactions in this Form 4 filing.
MaxLinear, Inc. chairman, president and CEO Kishore Seendripu reported equity awards rather than open-market trades. On February 20, 2026, he was granted 56,216 shares of common stock for the 2025 performance period under MaxLinear’s Executive Incentive Bonus Plan and Amended and Restated 2010 Equity Incentive Plan, and a separate performance-related grant of 49,651 shares of common stock tied to 2025 financial goals.
On February 18, 2026, he also received 138,136 restricted stock units (RSUs), each representing one MaxLinear share. These RSUs vest one-third on May 20, 2027 and then annually each May 20 until fully vested on May 20, 2029, assuming continued service. Some shares related to performance-based awards are deferred until employment ends or a qualifying change in control. The filing also lists substantial indirect holdings in multiple family and heritage trusts and a donor-advised fund, with Seendripu serving as trustee or advisor in several cases and expressly disclaiming beneficial ownership for certain child-focused trusts beyond any pecuniary interest.
Sennesael Kris reported acquisition or exercise transactions in this Form 4 filing.
MAXLINEAR, INC director Kris Sennesael received new equity awards in the form of restricted stock units (RSUs). On February 13, 2026, Sennesael was granted 2,052 RSUs and a separate award of 9,728 RSUs, each representing a right to receive one share of common stock.
The 2,052-unit award vests in full on the earlier of May 1, 2026 or the date immediately before the next annual stockholder meeting, provided Sennesael continues as a director. The 9,728-unit award vests in three equal annual installments on each anniversary of February 13, 2026, and will be fully vested on February 13, 2029, contingent on continued board service.
MaxLinear, Inc. (MXL) reported insider transactions by a director. On 10/29/2025, the director sold 9,055 shares of common stock at $15.8693. On 10/30/2025, the director sold 20,747 shares at a $15.3928 weighted-average price, with underlying trades between $15.39 and $15.415. Following these sales, the director held 12,141 shares directly.